Luciano Dalla-Pozza
Overview
Explore the profile of Luciano Dalla-Pozza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
855
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cain L, Mirochnik O, Stevens M, Kellie S, Padhye B, Keogh S, et al.
Genes Chromosomes Cancer
. 2024 Sep;
63(9):e23269.
PMID: 39291932
Introduction: Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) is a high risk form of ALL associated with dismal outcomes in the pre-tyrosine kinase inhibitor (TKI) era. Addition of a TKI...
2.
Lau L, Khuong-Quang D, Mayoh C, Wong M, Barahona P, Ajuyah P, et al.
Nat Med
. 2024 Jun;
30(7):1913-1922.
PMID: 38844796
Recent research showed that precision medicine can identify new treatment strategies for patients with childhood cancers. However, it is unclear which patients will benefit most from precision-guided treatment (PGT). Here...
3.
Mumford V, Raban M, Li L, Fitzpatrick E, Woods A, Merchant A, et al.
Br J Clin Pharmacol
. 2024 Mar;
90(7):1615-1626.
PMID: 38532641
Aims: The potential harm associated with medication errors is widely reported, but data on actual harm are limited. When actual harm has been measured, assessment processes are often poorly described,...
4.
Thomson A, Rehn J, Heatley S, Eadie L, Page E, Schutz C, et al.
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835427
B-cell acute lymphoblastic leukaemia (B-ALL) is characterised by diverse genomic alterations, the most frequent being gene fusions detected via transcriptomic analysis (mRNA-seq). Due to its hypervariable nature, gene fusions involving...
5.
Jeffrey A, Presgrave P, Walsh C, Sinn J, Kennedy D, Anazodo A, et al.
Leuk Lymphoma
. 2023 Jul;
64(11):1880-1883.
PMID: 37516923
No abstract available.
6.
Heilmann J, Vieth S, Moricke A, Attarbaschi A, Barbaric D, Bodmer N, et al.
Haematologica
. 2023 Apr;
108(12):3278-3286.
PMID: 37021527
Although initial central nervous system (CNS) involvement is rarely detected in childhood acute lymphoblastic leukemia (ALL), risk-adapted CNS-directed therapy is essential for all patients. Treatment intensity depends on the initial...
7.
Vanderniet J, Tsinas D, Wall C, Girgis C, London K, Keane C, et al.
Calcif Tissue Int
. 2023 Feb;
112(5):592-602.
PMID: 36810677
Aneurysmal bone cysts (ABC) are rare osteolytic, benign but often locally aggressive tumours of the long bones or vertebrae. For spinal ABC, surgical management, embolisation or sclerotherapy alone often carry...
8.
Schilstra C, McCleary K, Fardell J, Donoghoe M, McCormack E, Kotecha R, et al.
BMC Cancer
. 2022 Sep;
22(1):985.
PMID: 36109702
Background: Pediatric acute lymphoblastic leukemia (ALL) therapy is accompanied by treatment-related toxicities (TRTs) and impaired quality of life. In Australia and New Zealand, children with ALL are treated with either...
9.
Whitlock J, Malvar J, Dalla-Pozza L, Goldberg J, Silverman L, Ziegler D, et al.
Pediatr Blood Cancer
. 2022 Aug;
69(11):e29901.
PMID: 35989458
Children with relapse of T-cell acute lymphoblastic leukemia (T-ALL) or lymphoblastic lymphoma (T-LBL) have a dismal prognosis, largely due to difficulty attaining second remission. We hypothesized that adding etoposide and...
10.
Burns M, Zheng L, Dalla-Pozza L, Graf N, Walton J, Tumuluri K
Orbit
. 2022 Aug;
41(6):680-686.
PMID: 35938374
Purpose: The aim of this study is to report two cases of paediatric Yolk sac tumours (YST) of the orbit and sinonasal tract, with a major review on the subject....